Skip to main content Accessibility help
×
Home

Preparedness Tested: Severe Cerebral Malaria Presenting as a High-Risk Person Under Investigation for Ebola Virus Disease at a US Hospital

  • George L. Anesi (a1), Nuala J. Meyer (a1), John P. Reilly (a1), William D. Schweickert (a1), Mark E. Mikkelsen (a1), Emma V. Myers (a2), Edward T. Dickinson (a2), Matthew P. Kelly (a2), David A. Pegues (a3) and Neil O. Fishman (a3)...

Abstract

In 2019, a 42-year-old African man who works as an Ebola virus disease (EVD) researcher traveled from the Democratic Republic of Congo (DRC), near an ongoing EVD epidemic, to Philadelphia and presented to the Hospital of the University of Pennsylvania Emergency Department with altered mental status, vomiting, diarrhea, and fever. He was classified as a “wet” person under investigation for EVD, and his arrival activated our hospital emergency management command center and bioresponse teams. He was found to be in septic shock with multisystem organ dysfunction, including circulatory dysfunction, encephalopathy, metabolic lactic acidosis, acute kidney injury, acute liver injury, and diffuse intravascular coagulation. Critical care was delivered within high-risk pathogen isolation in the ED and in our Special Treatment Unit until a diagnosis of severe cerebral malaria was confirmed and EVD was definitively excluded.

This report discusses our experience activating a longitudinal preparedness program designed for rare, resource-intensive events at hospitals physically remote from any active epidemic but serving a high-volume international air travel port-of-entry.

Copyright

Corresponding author

Correspondence and reprint requests to George L. Anesi, Division of Pulmonary, Allergy, and Critical Care, University of Pennsylvania Perelman School of Medicine, 3400 Spruce Street, 824 Gates Building, Philadelphia, PA19104-6021 (e-mail: george.anesi@uphs.upenn.edu).

References

Hide All
1.World Health Organizationa. Health Emergencies Programme. Ebola virus disease, Democratic Republic of Congo. 2019. http://who.int/emergencies/diseases/ebola/drc-2019/situation-reports. Accessed February 27, 2020.
2.Wadman, MC, Schwedhelm, SS, Watson, S, et al.Emergency department processes for the evaluation and management of persons under investigation for Ebola virus disease. Ann Emerg Med. 2015;66:306314.
3.Malvy, D, McElroy, AK, de Clerck, H, et al.Ebola virus disease. Lancet. 2019;393:936-948.
4.Suen, LKP, Guo, YP, Tong, DWK, et al.Self-contamination during doffing of personal protective equipment by healthcare workers to prevent Ebola transmission. Antimicrob Resist Infect Control. 2018;7:157.
5.Ota-Sullivan, K, Blecker-Shelly, DL. Use of the rapid BinaxNOW malaria test in a 24-hour laboratory associated with accurate detection and decreased malaria testing turnaround times in a pediatric setting where malaria is not endemic. J Clin Microbiol. 2013;51:1567-1569.
6.Twomey, PS, Smith, BL, McDermott, C, et al.Intravenous artesunate for the treatment of severe and complicated malaria in the United States: clinical use under an investigational new drug protocol. Ann Intern Med. 2015;163:498-506.
7.Broadhurst, MJ, Brooks, TJ, Pollock, NR. Diagnosis of Ebola virus disease: past, present, and future. Clin Microbiol Rev. 2016;29:773-793.
8.Regules, JA, Beigel, JH, Paolino, KM, et al.A recombinant vesicular stomatitis virus Ebola vaccine. N Engl J Med. 2017;376:330-341.
9.Idro, R, Jenkins, NE, Newton, CR. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol. 2005;4:827-840.
10.Waxman, M, Aluisio, AR, Rege, S, Levine, AC. Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study. Lancet Infect Dis. 2017;17:654-660.
11.Jarrett, OD, Seward, JF, Fombah, AE, et al.Monitoring serious adverse events in the Sierra Leone trial to introduce a vaccine against Ebola. J Infect Dis. 2018;217:S24-S32.
12.Stowell, JR, Kessler, R, Lewiss, RE, et al.Critical care ultrasound: a national survey across specialties. J Clin Ultrasound. 2018;46:167-177.
13.Shrestha, GS, Weeratunga, D, Baker, K. Point-of-care lung ultrasound in critically ill patients. Rev Recent Clin Trials. 2018;13:15-26.
14.Bou Chebl, R, Kiblawi, S, El Khuri, C, et al.Use of contrast-enhanced ultrasound for confirmation of central venous catheter placement: systematic review and meta-analysis. J Ultrasound Med. 2017;36:2503-2510.

Keywords

Preparedness Tested: Severe Cerebral Malaria Presenting as a High-Risk Person Under Investigation for Ebola Virus Disease at a US Hospital

  • George L. Anesi (a1), Nuala J. Meyer (a1), John P. Reilly (a1), William D. Schweickert (a1), Mark E. Mikkelsen (a1), Emma V. Myers (a2), Edward T. Dickinson (a2), Matthew P. Kelly (a2), David A. Pegues (a3) and Neil O. Fishman (a3)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.